Evidence map›Paper›PMID 29507185›Full record

ArticleMolecular and cellular biology2018

Liver X Receptor Nuclear Receptors Are Transcriptional Regulators of Dendritic Cell Chemotaxis.

Susana Beceiro, Attila Pap, Zsolt Czimmerer, Tamer Sallam, Jose A Guillén, Germán Gallardo, Cynthia Hong, Noelia A-Gonzalez, Carlos Tabraue, Mercedes Diaz and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis.International journal of molecular sciences · 2018
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 3 countries.

Susana Beceiro *Instituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain.
Attila Pap *Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Zsolt Czimmerer *Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Tamer Sallam *Department of Pathology and Laboratory Medicine, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, USA.
Jose A GuillénInstituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain.
Germán GallardoInstituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain.
Cynthia HongDepartment of Pathology and Laboratory Medicine, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, USA.
Noelia A-GonzalezInstituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain.
Carlos TabraueInstituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain.
Mercedes DiazInstituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain.
Felix LopezInstituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain.
Jonathan MatalongaDepartmento de Biología Celular, Fisiología e Inmunología, Facultad de Biología, Universidad de Barcelona, Barcelona, Spain.
Annabel F ValledorDepartmento de Biología Celular, Fisiología e Inmunología, Facultad de Biología, Universidad de Barcelona, Barcelona, Spain.
Pilar DominguezDepartamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Carlos ArdavinDepartamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Cristina Delgado-MartinCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Santiago Partida-SanchezCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Jose Luis Rodriguez-FernandezCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Laszlo NagyDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Peter TontonozDepartment of Pathology and Laboratory Medicine, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, USA.
Antonio CastrilloInstituto de Investigaciones Biomédicas Alberto Sols CSIC-Universidad Autónoma de Madrid, Madrid, Spain acastrillo@iib.uam.es.
Instituto de Investigaciones Biomédicas Sols-Morreale · ESUniversidad Autónoma de Madrid · ESUniversity of California, Los Angeles · USCentro Nacional de Biotecnología · ESUniversitat de Barcelona · ESUniversity of Debrecen · HUCentro de Investigaciones Biológicas Margarita Salas · ESConsejo Superior de Investigaciones Científicas · ESDiscovery Institute · USThe Ohio State University · USUniversidad de Las Palmas de Gran Canaria · ES

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESISR01HL066088 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TONTONOZ, PETER J · 2001 to 2018
$5.4M
RNA-binding proteins in atherosclerosisR01HL139549 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Tamer Sallam · 2018 to 2026
$3.3M
Calcium dependent mechanisms of neutrophil dysfunction that contribute to cystic fibrosis pathobiologyR21AI120013 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI AMER, AMAL O, PARTIDA-SANCHEZ, SANTIAGO · 2016 to 2017
$427k
NHLBI NIH HHS P01 HL030568NHLBI NIH HHS R01 HL066088NHLBI NIH HHS R01 HL139549NIAID NIH HHS R21 AI120013
6 · The paper itself

Abstract

The liver X receptors (LXRs) are ligand-activated nuclear receptors with established roles in the maintenance of lipid homeostasis in multiple tissues. LXRs exert additional biological functions as negative regulators of inflammation, particularly in macrophages. However, the transcriptional responses controlled by LXRs in other myeloid cells, such as dendritic cells (DCs), are still poorly understood. Here we used gain- and loss-of-function models to characterize the impact of LXR deficiency on DC activation programs. Our results identified an LXR-dependent pathway that is important for DC chemotaxis. LXR-deficient mature DCs are defective in stimulus-induced migration

Indexed as

ADP-ribosyl Cyclase 1AnimalsCells, CulturedChemotaxisDendritic CellsInflammationLipid MetabolismLiver X ReceptorsMacrophagesMiceMice, Inbred C57BLMice, KnockoutOrphan Nuclear ReceptorsReceptors, Cytoplasmic and NuclearSignal TransductionADP-ribosyl Cyclase 1Liver X ReceptorsOrphan Nuclear ReceptorsReceptors, Cytoplasmic and NuclearCD38chemotaxisdendritic cellsinflammationliver X receptormacrophagesmigrationnuclear receptorsregulation of gene expressionsignal transduction

Identifiers

PMID29507185
PMCPMC5954201
OpenAlexW2794441296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.